Well the stock is having good volume and is moving up nice. This will be over 10 cents when HJOE lets a bit of news out and we will see good sales. I am thinking 20-25 cents by Christmas. They will grow this brand, they are forming a good relationship with Mr Checkout from the stuff on media and social media and those guys control over 300 Jobbers who sell to the independent stores. I think we will see a huge serge by Christmas and then in Jan and Feb when the chains set there new products for the year will see HJOE pick up more business, Were you buying when it was 1,5 cents? I was as much as I could get. I have always said this is a long term play and this stock will continue to grow. As a penny stock you don't find many gems like this. I happen to not only be a distributor for the company and a huge believer but a shareholder. I met the whole team and the new CEO Matt Veal he was the missing piece as the founders are marketing and sales guys and attorney but veal has 20 plus years running public companies and taking companies from the Red to the black. He personally told me he is in his 50's and this is the best thing he seen and why he is onboard. He said this a direct quote I am an account I am a numbers guy and it's just the laws of how things work. 5hr controls 90 percent of the energy business they are coke and a Pepsi has to come about they won't have that share for ever no brand ever does. We want to be Pepsi and we think we can be that. They have LTCG a great brand Git R Done what can be better for energy than that. These guys are going to Git R Done. Its a marathon with HJOE not a sprint folks. Tell your friends and family to get in now because I don't think we are going to see 1 and 2 and 3 cents again and its still a deal at 7 cents.
Well the stock is having good volume and is moving up nice.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Zenas BioPharma Investors Urged to Join Class Action Lawsuit
Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...
Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure
Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...
Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative
Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...
Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors
Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...
Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program
Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...
Continue Reading